Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation

被引：0
|
作者：
Beat Bojaxhiu
Arnoud J. Templeton
Olgun Elicin
Mohamed Shelan
Kathrin Zaugg
Marc Walser
Roland Giger
Daniel M. Aebersold
Alan Dal Pra
机构：
[1] Bern University Hospital and University of Bern,Department of Radiation Oncology, Inselspital
[2] University of Basel,Department of Medical Oncology, St. Claraspital Basel and Faculty of Medicine
[3] Bern University Hospital,Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital
[4] Stadtspital Triemli,Department of Radiation Oncology
[5] Center for Proton Therapy,undefined
[6] Paul Scherrer Institute,undefined
来源：
Radiation Oncology | / 13卷
关键词：
Head and neck; Squamous cell carcinoma; Inflammation; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-)radiation
    Bojaxhiu, Beat
    Templeton, Arnoud J.
    Elicin, Olgun
    Shelan, Mohamed
    Zaugg, Kathrin
    Walser, Marc
    Giger, Roland
    Aebersold, Daniel M.
    Dal Pra, Alan
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 13S - 14S
  • [2] Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
    Bojaxhiu, Beat
    Templeton, Arnoud J.
    Elicin, Olgun
    Shelan, Mohamed
    Zaugg, Kathrin
    Walser, Marc
    Giger, Roland
    Aebersold, Daniel M.
    Dal Pra, Alan
    [J]. RADIATION ONCOLOGY, 2018, 13
  • [3] Neutrophil-to-lymphocyte ratio (NLR) and survival in recurrent or metastatic head and neck cancer patients treated with immunotherapy
    Franco, A.
    Tresch, E.
    Sakji, I.
    Makhloufi, S.
    Abdeddaim, C.
    Julieron, M.
    Dansin, E.
    Chevalier, D.
    Mouawad, F.
    Lefebvre, G.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S676 - S676
  • [4] Neutrophil-to-lymphocyte ratio in head and neck cancer
    Haddad, Carol R.
    Guo, Linxin
    Clarke, Stephen
    Guminski, Alex
    Back, Michael
    Eade, Thomas
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (04) : 514 - 519
  • [5] The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy
    Cho, Yeona
    Kim, Jun Won
    Yoon, Hong In
    Lee, Chang Geol
    Keum, Ki Chang
    Lee, Ik Jae
    [J]. JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)
  • [6] Prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) on overall survival in patients treated with chemoradiotherapy for head and neck cancer
    Makhloufi, S.
    Lefebvre, G.
    Sakji, I.
    Feutry, F.
    Leroy, T.
    Penel, N.
    Coche, B.
    Fourquet, J.
    Ghestem, F.
    Julieron, M.
    Chevalier, D.
    Tresch, E.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [7] Neutrophil-to-Lymphocyte Ratio Predicts Survival in Head and Neck SCC Treated with Definitive Chemoradiotherapy
    Chandrasekara, S.
    Davis, S.
    Thomson, P.
    Haydon, A.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 56 - 56
  • [8] Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with clinical outcome in recurrent or metastatic head and neck cancer patients treated with nivolumab
    Ueda, Tsutomu
    Chikuie, Nobuyuki
    Takumida, Masaya
    Furuie, Hiromi
    Kono, Takashi
    Taruya, Takayuki
    Hamamoto, Takao
    Hattori, Minoru
    Ishino, Takashi
    Takeno, Sachio
    [J]. ACTA OTO-LARYNGOLOGICA, 2020, 140 (02) : 181 - 187
  • [9] Prognostic value of neutrophil-to-lymphocyte ratio in older patients with head and neck cancer
    Ku, Ja Yoon
    Roh, Jong-Lyel
    Kim, Sung-Bae
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (03) : 417 - 422
  • [10] Prognosis and Neutrophil-to-Lymphocyte Ratio in Nivolumab-treated Patients with Recurrent/Metastatic Head and Neck Cancer
    Ota, I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1174 - 1174
12345